The National Agency for Food and Drug Administration and Control (NAFDAC) has cautioned healthcare providers and the public against the use of certain malaria and HIV diagnostic kits following quality concerns raised by the World Health Organisation (WHO). In a public alert issued on Tuesday, NAFDAC said the WHO Prequalification service (WHO-PQT) released a Notice of Concern (NOC) after identifying “significant violations” during an audit of the manufacturing facility of Meril Diagnostics Private Limited in India. According to the agency, the audit findings showed that the manufacturer was not “operating in line with WHO requirements and applicable quality standards.” Although NAFDAC previously registered the affected products, the agency stressed that their “quality and safety are not ...